Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1980 Jan;56(651):57–58. doi: 10.1136/pgmj.56.651.57

Eosinophilic pleural effusion with high anti-DNA activity as a manifestation of systemic lupus erythematosus.

A J Wysenbeek, A I Pick, A Sella, Y Beigel, D Yeshurun
PMCID: PMC2425976  PMID: 6966798

Abstract

A patient, known to have systemic lupus erythematosus (SLE), presented with an eosinophilic pleural effusion. It is believed that SLE was the cause of her pleural effusion as increased levels of anti-DNA activity were found in the pleural fluid. Eosinophilic pleural effusion is a previosuly unreported observation in SLE patients (so far as the authors are aware), and the existence of increased anti-DNA activity in the pleural fluid may have value as an additional aid in the diagnosis of this disease.

Full text

PDF
57

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bower G. Eosinophilic pleural effusion. A condition with multiple causes. Am Rev Respir Dis. 1967 May;95(5):746–751. doi: 10.1164/arrd.1967.95.5.746. [DOI] [PubMed] [Google Scholar]
  2. CAMPBELL G. D., WEBB W. R. EOSINOPHILIC PLEURAL EFFUSION: A REVIEW WITH THE PRESENTATION OF SEVEN NEW CASES. Am Rev Respir Dis. 1964 Aug;90:194–201. doi: 10.1164/arrd.1964.90.2.194. [DOI] [PubMed] [Google Scholar]
  3. CHAPMAN J. S. Effect of solvents on eosinophile-stimulating substance of erythrocyte stroma. Proc Soc Exp Biol Med. 1961 Dec;108:566–569. doi: 10.3181/00379727-108-26998. [DOI] [PubMed] [Google Scholar]
  4. Campbell G. D., Ferrington E. Rheumatoid pleuritis with effusion. Dis Chest. 1968 May;53(5):521–527. doi: 10.1378/chest.53.5.521. [DOI] [PubMed] [Google Scholar]
  5. Cohen S., Ward P. A. In vitro and in vivo activity of a lymphocyte and immune complex-dependent chemotactic factor for eosinophils. J Exp Med. 1971 Jan 1;133(1):133–146. doi: 10.1084/jem.133.1.133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. DUBOIS E. L., TUFFANELLI D. L. CLINICAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS. COMPUTER ANALYSIS OF 520 CASES. JAMA. 1964 Oct 12;190:104–111. doi: 10.1001/jama.1964.03070150014003. [DOI] [PubMed] [Google Scholar]
  7. Hill G. S., Hinglais N., Tron F., Bach J. F. Systemic lupus erythematosus. Morphologic correlations with immunologic and clinical data at the time of biopsy. Am J Med. 1978 Jan;64(1):61–79. doi: 10.1016/0002-9343(78)90180-8. [DOI] [PubMed] [Google Scholar]
  8. Kokkola K., Valta R. Aetiology and findings in eosinophilic pleural effusion. Scand J Respir Dis Suppl. 1974;89:159–165. [PubMed] [Google Scholar]
  9. Pincus T., Schur P. H., Rose J. A., Decker J. L., Talal N. Measurement of serum DNA-binding activity in systemic lupus erythematosus. N Engl J Med. 1969 Sep 25;281(13):701–705. doi: 10.1056/NEJM196909252811304. [DOI] [PubMed] [Google Scholar]
  10. Wasserman S. I., Goetzl E. J., Ellman L., Austen K. F. Tumor-associated eosinophilotactic factor. N Engl J Med. 1974 Feb 21;290(8):420–424. doi: 10.1056/NEJM197402212900802. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES